<p>This delivery order against a larger research and development contract vehicle was awarded by an unnamed U.S. government agency to Research Triangle Research of Potomac, MD on May 15, 2003. The $4,999,439 potential value contract is for health services research and exploratory development with a completion date of March 30, 2007. No set-aside designation was used for this award to support the agency's research and exploratory development programs.</p>
This is a delivery order under the Medical Product Research and Development multiple-award contract, awarded by the U.S. Army Medical Command (MEDCOM) to PPD Development LP, a global contract research organization. The $495,898.15 cost-plus-fixed-fee contract is for market research, with the option for analysis of alternatives, related to hemorrhage detection. The award did not use a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher Scientific and has extensive...
This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to the prime contractor, Research Triangle Research, for research and development services related to health services. The contract has a ceiling value of $6,771,238.00 and was awarded on August 2, 2003 using a Cost Plus Fixed Fee pricing type. The period of performance extends to November 29, 2009. The contract is not set aside for any specific socioeconomic group. While the original solicitation is not...
This federal contract award was made by the Centers for Medicare and Medicaid Services (CMS), a civilian agency within the U.S. Department of Health and Human Services (HHS), to the prime contractor Research Triangle Institute (RTI International), a non-profit research organization. The $1,249,917.00 cost-plus-fixed-fee contract is for research and development (R&D) services related to health services. The award does not have a set-aside designation. RTI International has a broad portfolio...
This is a Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract, valued at $3,414,353.36, is for R&D in the area of biomedical applied research and exploratory development. Two subcontractors, Ambiopharm, Inc. and Shanghai Chempartner Co., LTD., have been engaged to provide custom peptides and bio compounds in...
This federal contract award was issued by the Centers for Medicare and Medicaid Services (CMS), a civilian agency within the U.S. Department of Health and Human Services, to the prime contractor Research Triangle Institute (RTI International), a non-profit research organization. The $3,944,969.54 cost-plus-fixed-fee contract is for research and development services related to health services and exploratory development, with an ultimate completion date of August 31, 2011. The contract does not...
This is a $900,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Aeronautics and Space Administration (NASA) to The DNA Medicine Institute, Inc., a for-profit Subchapter S Corporation. The contract is for the development of the "RHEALTH X WITH NON-INVASIVE CAPABILITIES FOR SCIENCE AND CREW HEALTH", a palm-sized device that can provide non-invasive health measurements, cell cytometry analysis, and multiplexed nanostrip tests. The goal is to...
This contract was awarded by the Defense Health Agency to Allied Technologies and Consulting, LLC, a Minority and Service Disabled Veteran Owned Small Business. The contract provides military medical research and development services, with a firm fixed price of $2,500.00 and a completion date of June 19, 2023. Allied Technologies and Consulting is a qualified federal contractor, holding several prime contracts with agencies like the National Institutes of Health and the Department of the Army...
This is a Delivery Order under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) awarded by the Defense Health Agency (DHA) to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The $516,110.95 cost-plus-fixed-fee contract supports an HIV Cohort Study, with a period of performance through October 13, 2022. The contract does not have a set-aside designation. PPD Development LP, a highly experienced federal...
This $2,078,017.00 federal contract award supports a joint project between the Agency for Healthcare Research and Quality (AHRQ) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to develop and test an open-source, clinician-facing, substitutable medical applications and reusable technologies (SMART) solution. The contract was awarded to Research Triangle Institute (RTI) International, a nonprofit research institute, under the Accelerating Change and Transformation...